Skip to main content

Table 4 Classification of Economic Impact and Quantifying of Cost Saving

From: Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study

Economic impactNumber of interventions (%)Costs
−1: Negative38 (16.0)11, 878 €
0: Null94 (39.7)0 €
+ 1: Positive105 (44.3)15,096 €
Total benefit 3218 €
\